By Dr. Mercola
Prostate cancer is one of the most common cancers in men. According to the latest statistics, about 181,000 men get diagnosed with prostate cancer every year in the U.S.
However, while common, it has a survival rate of about 86 percent. Of those diagnosed, about 26,000 die from the disease each year.1
Unfortunately, conventional diagnostics and treatment options for prostate cancer leave much to be desired. Conventional diagnosis includes PSA testing and biopsy, which are prone to false positives and carry risks of side effects. Continue reading »
Some of us, in the northern climes, are approaching that point of the year when we choose to huddle up in heated buildings, reduce our activity as well as the amount of time in the fresh air. Yes, a perfect environment for pathogens to circulate with a vengeance. Such conditions also herald the annual flu jab push. Or for the kids, the much more convenient nasal spray. We ask: why is it that British kids are being asked to line for the nasal spray when the leading US health authority on vaccines, the Centers for Disease Control (CDC), has declared that “the nasal spray flu vaccine (live attenuated influenza vaccine or LAIV) should not be used during 2016-2017”. The reason is simple: a study looking at the effectiveness of the nasal spray flu vaccine that was made available in May this year showed it did not confer any protection for those aged 2 to 17 who were studied.
News reports, such as this one from London’s Metro, are full of the benefits of the flu vaccine and are, in particular, encouraging parents to get their children vaccinated. For kids, it’s all about the nasal vaccine. Whereas in previous years children aged 2-4 were offered the conventional jab, it’s now on offer as a non-invasive nasal spray for children up to the age of 7.